Wieczorek, L., Brown, B. K., Wesberry, M., Ochsenbauer-Jambor, C., Kappes, J. C., Lora, N., … Polonis, V. R. (2009). P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific. In Retrovirology (Vol. 6). https://doi.org/10.1186/1742-4690-6-S3-P51

Wieczorek, L., B. K. Brown, M. Wesberry, C. Ochsenbauer-Jambor, J. C. Kappes, N. Lora, A. Gillis, et al. “P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific.” In Retrovirology, Vol. 6, 2009. https://doi.org/10.1186/1742-4690-6-S3-P51.

Wieczorek L, Brown BK, Wesberry M, Ochsenbauer-Jambor C, Kappes JC, Lora N, et al. P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific. In: Retrovirology. 2009.

Wieczorek, L., et al. “P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific.” Retrovirology, vol. 6, no. SUPPL. 3, 2009. Scopus, doi:10.1186/1742-4690-6-S3-P51.

Wieczorek L, Brown BK, Wesberry M, Ochsenbauer-Jambor C, Kappes JC, Lora N, Gillis A, Nzodom C, Molnar S, Michael NL, Montefiori D, Polonis VR. P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific. Retrovirology. 2009.